Alkermes (ALKS) Treasury Shares (2011 - 2026)
Alkermes (ALKS) reported Treasury Shares of $501.4 million for Q1 2026, up 11.92% year-over-year from $448.0 million in Q1 2025, and up 11.36% quarter-over-quarter from $450.3 million in Q4 2025.
Alkermes (ALKS) Treasury Shares (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Treasury Shares data on file, last reported at $501.4 million in Q1 2026.
- Treasury Shares for Q1 2026 came in at $501.4 million, up 11.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $501.4 million (up 11.92% YoY), and the FY2025 annual result was $450.3 million, up 7.4% from the prior year.
- Treasury Shares climbed to $501.4 million in Q1 2026 per ALKS's latest filing, from $450.3 million in the prior quarter.
- Over five years, Treasury Shares peaked at $17.1 million in Q1 2026 and troughed at -$15.4 million in Q2 2025.
- A 5-year average of $818976.2 and a median of $4.5 million in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares surged 124.09% in 2024, then increased 7.4% in 2025.
- A 5-year view of Treasury Shares shows it stood at $160.9 million in 2022, then advanced by 17.7% to $189.3 million in 2023, then soared by 121.43% to $419.3 million in 2024, then rose by 7.4% to $450.3 million in 2025, then rose by 11.36% to $501.4 million in 2026.
- Business Quant data shows ALKS's Treasury Shares at $501.4 million in Q1 2026, $450.3 million in Q4 2025, and $450.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 107.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 4.80 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.42 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 17.13 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 7.24 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 19.58 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 501.43 Mn |
| Mar 31, 2026 | 17.13 Mn |
| Mar 31, 2026 | 17.13 Mn |
| Mar 31, 2026 | 501.43 Mn |
| Dec 31, 2025 | 450.29 Mn |
| Dec 31, 2025 | 15.40 Mn |
| Dec 31, 2025 | 450.29 Mn |
| Dec 31, 2025 | 15.40 Mn |
| Sep 30, 2025 | 15.40 Mn |
| Sep 30, 2025 | 450.02 Mn |
| Sep 30, 2025 | 450.02 Mn |
| Sep 30, 2025 | 15.40 Mn |
| Jun 30, 2025 | 449.71 Mn |
| Jun 30, 2025 | -15.38 Mn |
| Jun 30, 2025 | -15.38 Mn |
| Jun 30, 2025 | 449.71 Mn |
| Mar 31, 2025 | -15.33 Mn |
| Mar 31, 2025 | 448.04 Mn |
| Mar 31, 2025 | 448.04 Mn |
| Mar 31, 2025 | -15.33 Mn |